This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Feb 1;178(2):258-259.

doi: 10.1001/jamainternmed.2017.7442.

Evolution of Herpes Zoster Vaccines and Their Economic Value

Mehdi Najafzadeh¹

Affiliations

Affiliation

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

PMID: 29297047
DOI: 10.1001/jamainternmed.2017.7442

Comment

Evolution of Herpes Zoster Vaccines and Their Economic Value

Mehdi Najafzadeh. JAMA Intern Med. 2018.

. 2018 Feb 1;178(2):258-259.

doi: 10.1001/jamainternmed.2017.7442.

Author

Mehdi Najafzadeh¹

Affiliation

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

PMID: 29297047
DOI: 10.1001/jamainternmed.2017.7442

No abstract available

PubMed Disclaimer

Comment on

Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults.
Le P, Rothberg MB. Le P, et al. JAMA Intern Med. 2018 Feb 1;178(2):248-258. doi: 10.1001/jamainternmed.2017.7431. JAMA Intern Med. 2018. PMID: 29297049 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information